Repurposing of currently available drugs is a valuable strategy to tackle the consequences
of COVID-19. Recently, several studies have investigated the effect of psychoactive drugs on …

During the current coronavirus disease 2019 (COVID-19) pandemic, symptoms of
depression are commonly documented among both symptomatic and asymptomatic …

The ongoing SARS-CoV-2 pandemic requires efficient and safe antiviral treatment
strategies. Drug repurposing represents a fast and low-cost approach to the development of …

An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in
the coronavirus disease pandemic, drastically affecting global health and economy. Though …

To circumvent time-consuming clinical trials, testing whether existing drugs are effective
inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this …

The current 2019 novel coronavirus disease (COVID-19), an emerging infectious disease, is
undoubtedly the most challenging pandemic in the 21st century. A total of 92,977,768 …

To circumvent time-consuming clinical trials, testing whether existing drugs are effective
inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this …

Purpose The absence of specific treatments for COVID-19 leads to an intense global effort in
the search for new therapeutic interventions and better clinical outcomes for patients. This …

Mapping non-canonical cellular pathways affected by approved medications can accelerate
drug repurposing efforts, which are crucial in situations with a global impact such as the …

The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter
development strategy in order to support clinicians with this difficult therapeutic dilemma …